This content is machine translated ESMO in Copenhagen and Singapore Immunotherapy puts lung cancer experts in turmoil Pembrolizumab returned to the international stage of lung cancer therapy with a thunderclap during the presentation of the KEYNOTE 024 trial at the 2016 ESMO Congress in Copenhagen. Lectures on…
